uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The effect of anabolic androgenic steroids on Calcitonin Gene-Related Peptide (CGRP) levels in the rat brain
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Show others and affiliations
2005 (English)In: Pharmacologyonline, Vol. 1, 177-195 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 1, 177-195 p.
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:uu:diva-92906OAI: oai:DiVA.org:uu-92906DiVA: diva2:166222
Available from: 2005-04-18 Created: 2005-04-18 Last updated: 2012-10-09Bibliographically approved
In thesis
1. Anabolic Androgenic Steroids: Effects on Neuropeptide Systems in the Rat Brain
Open this publication in new window or tab >>Anabolic Androgenic Steroids: Effects on Neuropeptide Systems in the Rat Brain
2005 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Anabolic-androgenic steroids (AAS) have been used in clinics for decades. The misuse of AAS has previously been attributed merely to sport athletes, taking AAS with intentions to increase muscle mass, enhance physical performance and to improve results in competitions. Today, the misuse of AAS has spread to adolescents and young adults not connected to sports. Alarmingly, many reports are pointing at severe psychiatric adverse effects among AAS abusers, which include mood swings, mania, anxiety, depression and aggression. Numerous examples of severe and often unprovoked violence and brutal crimes have been connected to AAS abuse and there is a strong need for a better understanding of the underlying biochemical events that might account for the adverse behaviors induced by AAS. The general aim of this thesis was to study the effect of chronic AAS administration on neuropeptide circuits in the rat brain associated with the regulation of rewarding effects, memory, anxiety, depression and aggression, using nandrolone decanoate as a prototype AAS.

Results demonstrated that daily administration of AAS to rats in doses comparable to those taken by AAS abusers, in certain brain structures significantly affected, a) the levels of the opioid peptides dynorphin B and Met-enkephalin-Arg6Phe7, b) the levels of the tachykinin substance P (SP), c) the density of the SP neurokinin 1 (NK1) receptor, d) the level of the SP metabolite SP1-7 that frequently exerts opposite effects to SP, e) the SP1-7 generating enzyme substance P endopeptidase (SPE) and finally, f) the levels of the neuropeptide calcitonin gene-related peptide (CGRP) often co-localized with SP. The alterations seen in the levels and activities of these neurochemical components are in many aspects compatible with behaviors typified among AAS abusers.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2005. 60 p.
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 9
Keyword
Biological research on drug dependence, Anabolic androgenic steroids, Nandrolone decanoate, Substance P, NK1 receptor, Substance P(1-7), Endopeptidase, Opioids, Calcitonin gene-related peptide, Radioimmunoassay, Autoradiography, Central nervous system, Rats, Biologisk beroendeforskning
National Category
Pharmacology and Toxicology
Identifiers
urn:nbn:se:uu:diva-5745 (URN)91-554-6214-6 (ISBN)
Public defence
2005-05-11, B41, BMC, Husargatan 3, Uppsala, 09:15
Opponent
Supervisors
Available from: 2005-04-18 Created: 2005-04-18Bibliographically approved

Open Access in DiVA

No full text

Other links

http://pharmacologyonline.silae.it/files/archives/2005/vol1/09_Hallberg_CGRP.pdf

Authority records BETA

Hallberg, MathiasMagnusson, KristinaKindlundh, AnnaNyberg, Fred

Search in DiVA

By author/editor
Hallberg, MathiasMagnusson, KristinaKindlundh, AnnaNyberg, Fred
By organisation
Department of Pharmaceutical Biosciences
Neurosciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 509 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf